Microfluidics Global Market Report 2026

Microfluidics is the science and technology of devices designed to process or manipulate small volumes of fluid (ranging from 10-9 to 10-18L) through channels with widths of a few tens to several hundred micrometers. Microfluidic devices are capable of performing chemical analysis on small amounts of liquid, such as droplets of blood. These devices have emerged as an alternative to conventional laboratory techniques, offering the potential to conduct complete laboratory protocols on a single small chip.

The primary types of microfluidics encompass silicone-based microfluidics, glass-based microfluidics, and polymer-based microfluidics. Silicon-based microfluidics involve the use of micro-manufactured devices for chip-scale management of tiny volumes of fluids. These devices are created by combining silicon with other materials such as glass, polymers, or other substances. Silicon-based microfluidics find applications in various fields, including industrial and environmental processes, drug delivery, pharmaceutical and life science research, analysis, and clinical and veterinary diagnostics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs on imported microfluidic materials and devices have impacted the market by increasing production costs and causing delays in supply chains, particularly affecting polymer-based and silicon-based microfluidics. Regions such as north america, europe, and asia-pacific are most impacted. However, tariffs have also encouraged local manufacturing, domestic sourcing, and investment in innovative, cost-efficient microfluidic technologies to maintain competitiveness.

The microfluidics market research report is one of a series of new reports from The Business Research Company that provides microfluidics market statistics, including microfluidics industry global market size, regional shares, competitors with a microfluidics market share, detailed microfluidics market segments, market trends and opportunities, and any further data you may need to thrive in the microfluidics industry. This microfluidics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The microfluidics market size has grown rapidly in recent years. It will grow from $10.33 billion in 2025 to $11.89 billion in 2026 at a compound annual growth rate (CAGR) of 15.0%. The growth in the historic period can be attributed to growth in laboratory-on-a-chip research, increasing demand for miniaturized diagnostic devices, adoption in pharmaceutical R&D, expansion of analytical and clinical testing, development of silicon and glass-based microfluidic devices.

The microfluidics market size is expected to see rapid growth in the next few years. It will grow to $20.73 billion in 2030 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to rising adoption in point-of-care diagnostics, growth in personalized medicine applications, expansion of polymer-based microfluidics, increasing integration with IoT and smart lab systems, advancements in high-throughput screening technologies. Major trends in the forecast period include integration of microfluidics in drug delivery systems, adoption of microfluidics in clinical diagnostics, expansion of pharmaceutical and life science research applications, development of industrial and environmental microfluidics solutions, advancement in high-precision fluid manipulation technologies.

The rise in clinical studies for cell-based therapies has significantly contributed to the growth of the microfluidics market during the historical period. Microfluidics has emerged as a promising platform for advancing biomanufacturing in drug, gene, and cell therapies by enabling enhanced synthesis of nanoscale drug and gene delivery systems, microencapsulation of drugs or cells, intracellular delivery of macromolecules, and the fabrication of macroscale constructs from micro-nano fibers. For example, in July 2023, the American Society of Gene and Cell Therapy, a US-based medical and scientific development organization, reported a 58% increase in non-oncology gene and cell therapy clinical trials in the second quarter of 2023 compared to the first quarter. Thus, the growing number of clinical studies focused on cell-based therapies is expected to drive the growth of the microfluidics market during the forecast period.

Major companies operating in the microfluidics market are concentrating on developing sophisticated solutions, such as lab-on-a-chip devices and integrated microfluidic platforms, to improve diagnostic accuracy, shorten sample processing time, and enhance point-of-care testing capabilities. Lab-on-a-chip devices are miniaturized systems that consolidate multiple laboratory functions onto a single chip, allowing faster and more precise analyses with minimal sample volumes. For example, in March 2024, Takara Bio, a Japan-based scientific reagents manufacturer, introduced the first commercial dissolvable microfluidic lentiviral transduction enhancer. This product employs a unique dissolvable microfluidic platform that enables precise regulation of the transduction process, improving the delivery of lentiviral vectors into target cells. The enhancer is designed to substantially boost the efficiency of lentiviral transduction, which is vital for gene therapy applications, ensuring more effective gene delivery into cells. Additionally, the microfluidic system streamlines the experimental setup, making it user-friendly for researchers without requiring extensive technical expertise.

In January 2025, bioMerieux SA, a France-based global leader in in vitro diagnostics, finalized the acquisition of SpinChip Diagnostics ASA for an enterprise value of approximately 0.15 USD billion (EUR 138 million). With this acquisition, bioMerieux seeks to strengthen its microfluidics-enabled point-of-care diagnostic capabilities by incorporating SpinChip's advanced microfluidic immunoassay technology, which provides rapid, high-sensitivity results from small blood samples and broadens the company's diagnostic portfolio. SpinChip Diagnostics ASA is a Norway-based diagnostics firm that develops next-generation microfluidic testing solutions for both acute and chronic disease diagnosis.

Major companies operating in the microfluidics market report are Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Fluidigm Corporation, Dolomite Microfluidics, PerkinElmer, Inc., Sphere Fluidics Limited, Micronit Micro Technologies B.V., Fluigent, Elveflow, Cellix Ltd., Microliquid S.L., Biosurfit S.A., FlowJEM, uFluidix, QuantWave Technologies Inc., Harvard Bioscience, Inc., Abaxis, Inc., OPKO Health, Inc., Abbott, Stamm

North America was the largest region in the microfluidics market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the microfluidics market are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the microfluidics market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The microfluidics market includes revenues earned by entities by developing molecular sensors based on bioassays, such as DNA amplification and analysis, cell separation, and immunoassay, among many more examples. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Microfluidics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses microfluidics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for microfluidics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The microfluidics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Material: Silicon-Based Microfluidics; Glass-Based Microfluidics; Polymer-Based Microfluidics
• 2) By Technology: Droplet-Based Microfluidics; Continuous-Flow Microfluidics; Digital Microfluidics; Paper-Based Microfluidics; Centrifugal Microfluidics; Organ-on-a-Chip Platforms
• 3) By Application: Industrial And Environmental; Drug Delivery; Pharmaceutical And Life Science Research; Analysis; Clinical And Veterinary Diagnostics
• Subsegments:
• 1) By Silicon-Based Microfluidics: Bulk Micromachined Silicon; Silicon-on-Insulator (SOI); Nano-Structured Silicon
• 2) By Glass-Based Microfluidics: Borosilicate Glass; Fused Silica Glass; Soda-Lime Glass
• 3) By Polymer-Based Microfluidics: Polydimethylsiloxane (PDMS); Poly(methyl methacrylate) (PMMA); Polycarbonate (PC)
• Companies Mentioned: Thermo Fisher Scientific; Agilent Technologies; Bio-Rad Laboratories; Fluidigm Corporation; Dolomite Microfluidics; PerkinElmer, Inc.; Sphere Fluidics Limited; Micronit Micro Technologies B.V.; Fluigent; Elveflow; Cellix Ltd.; Microliquid S.L.; Biosurfit S.A.; FlowJEM; uFluidix; QuantWave Technologies Inc.; Harvard Bioscience, Inc.; Abaxis, Inc.; OPKO Health, Inc.; Abbott; Stamm
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.